AB Enzymes Statement - Covid-19

2020/4/1

We are constantly monitoring developments regarding the coronavirus/COVID-19 outbreak and continue to follow local government and World Health Organization (WHO) advice relevant to our global network of sites. Safeguarding the health and wellbeing of our employees and their families, while continuing to supply solutions for our customers’ products and applications, is our priority.

We have organised our operations and safety protocols to strictly follow the WHO guidelines and local governmental regulations, and all our employees have been fully trained on additional precautions. We have taken measures to ensure business continuity and mitigate the risk of the virus impacting our operations, supply chains and stakeholders who rely on us to help them responsibly provide enzyme preparations for industrial applications worldwide. Such planning is helping us support our teams across our facilities which means that we are operating safely, and our supply remains undisrupted.

Our manufacturing site has been qualified as an essential industry and we are applying recommended guidance to ensure employees’ safety as well as adequate product supply meeting our customers demand. We will continue to partner and support our customers and stakeholders during this challenging period.